.png)
ORLANDO, Fla. — Patients with type 1 and 2 diabetes who delay treatment with recommended statin therapy to address the well-known high risk for cardiovascular (CV) events show significantly higher rates of CV events over a 10-year follow-up compared with those treated without delay. “We found that delays in statin therapy — even by just ...
Copyright © 2023 ampere.org. All Rights Reserved
